Turck Dominique, Bresson Jean-Louis, Burlingame Barbara, Dean Tara, Fairweather-Tait Susan, Heinonen Marina, Hirsch-Ernst Karen Ildico, Mangelsdorf Inge, McArdle Harry J, Naska Androniki, Neuhäuser-Berthold Monika, Nowicka Grażyna, Pentieva Kristina, Sanz Yolanda, Sjödin Anders, Stern Martin, Tomé Daniel, Van Loveren Henk, Vinceti Marco, Willatts Peter, Martin Ambroise, Strain Sean Jj, Siani Alfonso
EFSA J. 2018 May 24;16(5):e05266. doi: 10.2903/j.efsa.2018.5266. eCollection 2018 May.
Following an application from Unilever NV, submitted for authorisation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 via the Competent Authority of Ireland, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to black tea and improvement of attention. The scope of the application was proposed to fall under a health claim based on newly developed scientific evidence. The food proposed by the applicant as the subject of the health claim is black tea. The Panel considers that black tea characterised by its content of tea solids, caffeine and l-theanine, which is the subject of the health claim, is sufficiently characterised in relation to the claimed effect. The claimed effect proposed by the applicant is 'improves attention'. The Panel considers that improvement of attention is a beneficial physiological effect. Three human intervention studies provided by the applicant show an effect of black tea on attention under the conditions of used proposed by the applicant. The applicant proposed that the claimed effect depends on the concerted action of two substances, caffeine and l-theanine, both of which are present in black tea. The Panel considers that the effect of black tea on attention observed in the three human intervention studies provided by the applicant can be explained by its caffeine content. The Panel concludes that a cause and effect relationship has been established between the consumption of black tea and improvement of attention. The Panel considers that the effect of black tea on attention can be explained by its caffeine content. The following wording reflects the scientific evidence: 'Owing to its caffeine content, black tea improves attention'. In order to obtain the claimed effect, 2-3 servings of black tea providing at least 75 mg of caffeine in total should be consumed within 90 min.
应联合利华股份有限公司(Unilever NV)依据欧盟法规(EC)No 1924/2006第13(5)条通过爱尔兰主管当局提交的健康声称授权申请,欧洲食品安全局(EFSA)的营养产品、营养和过敏专家组(NDA)被要求就一项关于红茶与注意力改善的健康声称的科学依据发表意见。该申请的范围被提议属于基于新开发科学证据的健康声称。申请人提议作为健康声称主题的食品是红茶。专家组认为,作为健康声称主题的、以茶固体、咖啡因和L-茶氨酸含量为特征的红茶,就所声称的效果而言具有充分的特征描述。申请人声称的效果是“改善注意力”。专家组认为注意力的改善是一种有益的生理效应。申请人提供的三项人体干预研究表明,在申请人提议的使用条件下,红茶对注意力有影响。申请人提议所声称的效果取决于两种物质——咖啡因和L-茶氨酸的协同作用,这两种物质都存在于红茶中。专家组认为,申请人提供的三项人体干预研究中观察到的红茶对注意力的影响可以用其咖啡因含量来解释。专家组得出结论,饮用红茶与注意力改善之间已建立因果关系。专家组认为,红茶对注意力的影响可以用其咖啡因含量来解释。以下表述反映了科学证据:“由于其咖啡因含量,红茶可改善注意力”。为获得所声称的效果,应在90分钟内饮用2 - 3份红茶,总共提供至少75毫克咖啡因。